1. Home
  2. DRCT vs PRFX Comparison

DRCT vs PRFX Comparison

Compare DRCT & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Direct Digital Holdings Inc.

DRCT

Direct Digital Holdings Inc.

N/A

Current Price

$2.98

Market Cap

2.3M

Sector

Technology

ML Signal

N/A

Logo PainReform Ltd.

PRFX

PainReform Ltd.

N/A

Current Price

$1.64

Market Cap

2.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DRCT
PRFX
Founded
2018
2007
Country
United States
Israel
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3M
2.6M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
DRCT
PRFX
Price
$2.98
$1.64
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$32.00
N/A
AVG Volume (30 Days)
28.7K
3.9M
Earning Date
05-08-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$34,694,000.00
N/A
Revenue This Year
$5.42
N/A
Revenue Next Year
$9.50
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.04
$0.58
52 Week High
$7.21
$5.39

Technical Indicators

Market Signals
Indicator
DRCT
PRFX
Relative Strength Index (RSI) 47.66 48.92
Support Level $2.73 $1.00
Resistance Level $2.98 $2.89
Average True Range (ATR) 0.22 0.59
MACD -0.06 0.05
Stochastic Oscillator 33.32 9.11

Price Performance

Historical Comparison
DRCT
PRFX

About DRCT Direct Digital Holdings Inc.

Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.

About PRFX PainReform Ltd.

PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasize reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the company's lead product, is based on the local anesthetic ropivacaine and targets the postoperative pain relief market. The company has two operating segments composed of the Clinical Development segment, which facilitates the development of potential new drug compounds, and the Solar segment, which comprises the design and development of the company's intellectual property and the sale related service offerings.

Share on Social Networks: